1 Department of Emergency Medicine Research, Lehigh Valley Health Network , Allentown, Pennsylvania.
2 Department of Obstetrics and Gynecology, Drexel University College of Medicine , Philadelphia, Pennsylvania.
J Womens Health (Larchmt). 2018 Mar;27(3):258-270. doi: 10.1089/jwh.2017.6458. Epub 2017 Nov 17.
To identify factors that influence women's participation in clinical research.
We administered a survey in outpatient and inpatient populations of Obstetrics and Gynecology facilities of six institutions located in four states. The survey included questions regarding any of the participant's past experiences in clinical research and the factors that would influence their participation in clinical research. Analyses included descriptive statistics and a Principal Component Analysis.
The analysis included 3,773 respondents; 2,477 (68.1%) were pregnant. The majority of participants were Caucasian (1,453, 40.2%), followed by Hispanic (933, 25.8%), African American/black (744, 20.6%), other minorities (270, 7.5%), and multiracial (212, 5.9%). Ten potential motivating factors and 10 potential barriers were assessed. The greatest motivating factor was "how well research is explained" (mean = 2.87) while "risk of unknown side effects" was the greatest barrier (mean = 3.07) for women's participation in clinical trials. Among six helpful resources assessed, "material in my own language" was scored as the highest (mean = 2.8) in facilitating women's decision to participate. For "risk to the fetus/future fertility" as a barrier, pregnant women's score (mean = 3.25) was significantly higher than nonpregnant women's score (mean = 2.37).
Overall, the risk of unknown side effects discourages women in general, and the risk to the fetus/future fertility discourages pregnant women the most from participating in clinical trials. However, explaining a study well and providing written material in the patients' own language may increase their willingness to participate.
确定影响女性参与临床研究的因素。
我们在六家机构的妇产科门诊和住院人群中进行了一项调查。该调查包括参与者过去在临床研究中的任何经历以及影响他们参与临床研究的因素。分析包括描述性统计和主成分分析。
分析包括 3773 名受访者;2477 名(68.1%)处于妊娠状态。大多数参与者为白种人(1453 人,40.2%),其次为西班牙裔(933 人,25.8%)、非裔/黑人(744 人,20.6%)、其他少数民族(270 人,7.5%)和多种族裔(212 人,5.9%)。评估了 10 个潜在的激励因素和 10 个潜在的障碍。最大的激励因素是“研究解释得如何”(平均值=2.87),而“未知副作用的风险”是女性参与临床试验的最大障碍(平均值=3.07)。在评估的六种有帮助的资源中,“我自己语言的材料”被评为最高(平均值=2.8),有助于女性做出参与的决定。对于“对胎儿/未来生育能力的风险”作为障碍,孕妇的得分(平均值=3.25)明显高于非孕妇的得分(平均值=2.37)。
总体而言,未知副作用的风险使一般女性望而却步,而对胎儿/未来生育能力的风险使孕妇最不愿意参与临床试验。然而,充分解释研究并提供患者自己语言的书面材料可能会增加他们参与的意愿。